Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-15,400
Closed -$5.04M 1516
2025
Q4
$5.04M Buy
+15,400
New +$4.89M 0.03% 516
2025
Q2
Sell
-22,500
Closed -$7.01M 1409
2025
Q1
$7.01M Buy
+22,500
New +$6.64M 0.07% 285
2024
Q3
Sell
-10,000
Closed -$3.12M 1247
2024
Q2
$3.12M Buy
+10,000
New +$2.94M 0.05% 386
2023
Q3
Sell
-125,000
Closed -$27.8M 1257
2023
Q2
$27.8M Buy
+125,000
New +$29M 0.49% 32
2023
Q1
Sell
-9,500
Closed -$2.5M 1060
2022
Q4
$2.5M Buy
+9,500
New +$2.55M 0.04% 501
2021
Q3
Sell
-1,000
Closed -$244K 1484
2021
Q2
$244K Sell
1,000
-99,000
-99% -$24.4M ﹤0.01% 1157
2021
Q1
$24.9M Buy
+100,000
New +$23.9M 0.54% 24
2020
Q3
Sell
-100,000
Closed -$23.6M 1013
2020
Q2
$23.6M Buy
+100,000
New +$22.8M 0.79% 10
2019
Q3
Sell
-261,300
Closed -$48.2M 692
2019
Q2
$48.2M Buy
+261,300
New +$46.8M 2.42% 2

Other funds holding AMGN

Caption Management's AMGN Position: Q2 2025 in Review

Caption Management sold out of Amgen (AMGN) in Q2 2025, closing a stake of 7,550 shares — an estimated $2.14M sold.

Caption Management first reported a position in AMGN in Q1 2021 and held it in 7 quarters. The position peaked at $23.6M in Q1 2021. 2,851 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.

  • Caption Management reported no remaining Amgen position as of Q2 2025 after selling out during the quarter.
  • Caption Management sold 7,550 Amgen shares in Q2 2025, an estimated $2.14M.
  • Caption Management first reported a position in Amgen in Q1 2021 and held it in 7 quarters.
  • Caption Management's Amgen position peaked at $23.6M in Q1 2021.
  • 2,851 funds tracked by Wall St. Rank held Amgen as of Q2 2025.

Based on Caption Management's 13F filing for Q2 2025, filed 14 Aug 2025.